A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells

[1]  A. Fatica,et al.  Role of microRNAs in myeloid differentiation. , 2008, Biochemical Society transactions.

[2]  Laura Mosca,et al.  An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma , 2008, BMC medical genomics.

[3]  M. Washington,et al.  Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer , 2008, Oncogene.

[4]  M. Fabbri,et al.  MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications , 2008, Leukemia.

[5]  O. Kirak,et al.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 , 2008, Nature.

[6]  C. Croce,et al.  MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia , 2007, Oncogene.

[7]  R. Shivdasani.  MicroRNAs: regulators of gene expression and cell differentiation. , 2006, Blood.

[8]  Daniel G Tenen,et al.  ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. , 2004, Blood.

[9]  Alessandro Fatica,et al.  A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.

[10]  Alberto Riva,et al.  MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes , 2005, BMC Bioinformatics.

[11]  U. Testa,et al.  Impaired myelopoiesis in mice devoid of interferon regulatory factor 1 , 2004, Leukemia.

[12]  I. Bozzoni,et al.  A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Daniel G. Tenen,et al.  Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.

[14]  A. Kimchi,et al.  Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. , 2002, Cancer research.

[15]  J. C. James,et al.  Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. , 2002, The Journal of biological chemistry.

[16]  M. Lanotte,et al.  Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes , 2001, Oncogene.

[17]  T. Taniguchi,et al.  IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.

[18]  D. Crabb,et al.  Sensitivity of virally-driven luciferase reporter plasmids to members of the steroid/thyroid/retinoid family of nuclear receptors , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[20]  J. Licht,et al.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. , 1999, Blood.

[21]  T. Graf,et al.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. , 1998, Genes & development.

[22]  R. Pine,et al.  Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. , 1996, Blood.

[23]  al. et,et al.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.